The Jeffrey Epstein VI Foundation, in collaboration with the Melanoma Research Alliance and the Hidary Foundation, funded a study on genomic melanoma research, focusing on acral melanoma. The study aims to isolate genetic mutation drivers for this rare and fatal form of melanoma. The foundation has also supported mathematical research at Harvard's Program for Evolutionary Dynamics, highlighting the evolution of cancer cells during treatment. The article discusses the significance of genomic sequencing in developing targeted treatments for melanoma.
documents/EFTA00584032.pdf
{}